Book contents
- Perinatal Neuropathology
- Perinatal Neuropathology
- Copyright page
- Contents
- Preface
- Acknowledgments
- Abbreviations
- Section I Techniques and Practical Considerations
- Section 2 Human Nervous System Development
- Section 3 Stillbirth
- Section 4 Disruptions / Hypoxic-Ischemic Injury
- Section 5 Malformations
- Section 6 Perinatal Neurooncology
- Section 7 Spinal and Neuromuscular Disorders
- Arthrogryposis
- Spinal Muscular Atrophy
- Early-Onset Hereditary Neuropathies
- Congenital Muscle Disorders
- Chapter 52 Congenital Myasthenic Syndromes
- Chapter 53 Congenital Muscular Dystrophies
- Chapter 54 Congenital Myopathies
- Chapter 55 Other Congenital Muscle Disorders
- Section 8 Eye Disorders
- Section 9 Infections: In Utero Infections
- Section 10 Metabolic / Toxic Disorders: Storage Diseases
- Section 11 Forensic Neuropathology
- Appendix 1 Technical Considerations in Perinatal CNS
- Index
- References
Chapter 53 - Congenital Muscular Dystrophies
from Congenital Muscle Disorders
Published online by Cambridge University Press: 07 August 2021
Book contents
- Perinatal Neuropathology
- Perinatal Neuropathology
- Copyright page
- Contents
- Preface
- Acknowledgments
- Abbreviations
- Section I Techniques and Practical Considerations
- Section 2 Human Nervous System Development
- Section 3 Stillbirth
- Section 4 Disruptions / Hypoxic-Ischemic Injury
- Section 5 Malformations
- Section 6 Perinatal Neurooncology
- Section 7 Spinal and Neuromuscular Disorders
- Arthrogryposis
- Spinal Muscular Atrophy
- Early-Onset Hereditary Neuropathies
- Congenital Muscle Disorders
- Chapter 52 Congenital Myasthenic Syndromes
- Chapter 53 Congenital Muscular Dystrophies
- Chapter 54 Congenital Myopathies
- Chapter 55 Other Congenital Muscle Disorders
- Section 8 Eye Disorders
- Section 9 Infections: In Utero Infections
- Section 10 Metabolic / Toxic Disorders: Storage Diseases
- Section 11 Forensic Neuropathology
- Appendix 1 Technical Considerations in Perinatal CNS
- Index
- References
Summary
These are genetically driven, progressive muscle disorders, noted in the neonatal period (i.e., congenital), within the first year of life (infantile), or during toddlerhood (see Table 53.1 for entities seen in these age groups).
- Type
- Chapter
- Information
- Perinatal Neuropathology , pp. 317 - 323Publisher: Cambridge University PressPrint publication year: 2021
References
Bönnemann, CG, Wang, CH, Quijano-Roy, S, Deconinck, N, Bertini, E, Ferreiro, A, Muntoni, F, Sewry, C, Béroud, C, Mathews, KD, Moore, SA, Bellini, J, Rutkowski, A, North, KN, on behalf of Members of the International Standard of Care Committee for Congenital Muscular Dystrophies.Diagnostic approach to the congenital muscular dystrophies. Neuromuscul Disord 2014:24(4):289–311.Google Scholar
Dowling, JJ, Gonorazky, HD, Cohn, RD, Campbell, C. Treating pediatric muscular disorders: the future is now. Am J Med Genet 2018:176:804–41.CrossRefGoogle ScholarPubMed
Leung, DG. Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review. J Neurol 2017 July;264(7):1320–33.CrossRefGoogle ScholarPubMed
Amato, AA, Russell, JA. Neuromuscular Disorders, 2nd ed. New York: McGraw Hill Education, 2016.Google Scholar
Quijano-Roy, S, Sparks, SE, Rutkowski, A. LAMA2-related muscular dystrophy. GeneReviews. June 7, 2012. www.ncbi.nlm.nih.gov/books/NBK97333/.Google Scholar
Sellick, GS, Longman, C, Brockington, M, Mahjneh, I, Sagi, L, Bushby, K, Topaloğlu, H, Muntoni, F, Houlston, RS. Localisation of merosin-positive congenital muscular dystrophy to chromosome 4p16.3. Hum Genet. 2005 117(2–3):207–12.CrossRefGoogle ScholarPubMed
Yurchenco, PD, McKee, KK, Reinhard, JR, Rüegg, MA. Laminin-deficient muscular dystrophy: Molecular pathogenesis and structural repair strategies. Matrix Biol. 2018;71–2:174–87.Google Scholar
Yoshida-Moriguchi, T, Campbell, KP. Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane. Glycobiology. 2015; 25(7):702–13.CrossRefGoogle ScholarPubMed
Bouchet-Séraphin, C, Vuillaumier-Barrot, S, Seta, N. Dystroglycanopathies: about numerous genes involved in glycosylation of one single glycoprotein. J Neuromuscul Dis. 2015;2(1):27–38.CrossRefGoogle ScholarPubMed
Devisme, L, Bouchet, C, Gonzalès, M, Alanio, E, Bazin, A, Bessières, B, Bigi, N, Blanchet, P, Bonneau, D, Bonnières, M, Bucourt, M, Carles, D, Clarisse, B, Delahaye, S, Fallet-Bianco, C, Figarella-Branger, D, Gaillard, D, Gasser, B, Delezoide, AL, Guimiot, F, Joubert, M, Laurent, N, Laquerrière, A, Liprandi, A, Loget, P, Marcorelles, P, Martinovic, J, Menez, F, Patrier, S, Pelluard, F, Perez, MJ, Rouleau, C, Triau, S, Attié-Bitach, T, Vuillaumier-Barrot, S, Seta N, Encha-Razavi F. Cobblestone lissencephaly: neuropathological subtypes and correlations with genes of dystroglycanopathies.Brain. 2012;135(Pt 2):469–82.Google Scholar
Godfrey, C, Foley, AR, Clement, E, Muntoni, F. Dystroglycanopathies: coming into focus. Curr Opin Genet Dev. 2011;21(3):278–85.CrossRefGoogle ScholarPubMed
Willer, T, Lee, H, Lommel, M, Yoshida-Moriguchi, T, de Bernabe, DB, Venzke, D, Cirak, S, Schachter, H, Vajsar, J, Voit, T, Muntoni, F, Loder, AS, Dobyns, WB, Winder, TL, Strahl, S, Mathews, KD, Nelson, SF, Moore, SA, Campbell, KP. ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. Nat Genet. 2012;44(5):575–80.Google Scholar
Wallace, SE, Conta, JH, Winder, TL, Willer, T, Eskuri, JM, Haas, R, Patterson, K, Campbell, KP, Moore, SA, Gospe, SM Jr. A novel missense mutation in POMT1 modulates the severe congenital muscular dystrophy phenotype associated with POMT1 nonsense mutations. Neuromuscul Disord. 2014;24(4):312–20.Google Scholar
Chang, W, Winder, TL, LeDuc, CA, Simpson, LL, Millar, WS, Dungan, J, Ginsberg, N, Plaga, S, Moore, SA, Chung, WK. Founder Fukutin mutation causes Walker-Warburg syndrome in four Ashkenazi Jewish families. Prenat Diagn. 2009;29(6):560–9.Google Scholar
Lampe, AK, Flanigan, KM, Bushby, KM, Hicks, D. Collagen type VI-related disorders. GeneReviews, last updated August 9, 2012. www.ncbi.nlm.nih.gov/books/NBK1503/.Google Scholar
Bönnemann, CG. The collagen VI-related myopathies: muscle meets its matrix. Nat Rev Neurol. 2011;7(7):379–90.CrossRefGoogle ScholarPubMed
Yonekawa, T, Nishino, I. Ullrich congenital muscular dystrophy: clinicopathological features, natural history and pathomechanism(s). J Neurol Neurosurg Psychiatry. 2015;86(3):280–7.CrossRefGoogle ScholarPubMed
Komaki, H, Hayashi, YK, Tsuburaya, R, Sugie, K, Kato, M, Nagai, T, Imataka, G, Suzuki, S, Saitoh, S, Asahina, N, Honke, K, Higuchi, Y, Sakuma, H, Saito, Y, Nakagawa, E, Sugai, K, Sasaki, M, Nonaka, I, Nishino, I. Inflammatory changes in infantile-onset LMNA-associated myopathy. Neuromuscul Disord. 2011;21(8):563–8.CrossRefGoogle ScholarPubMed
Quijano-Roy, S, Mbieleu, B, Bönnemann, CG, Jeannet, PY, Colomer, J, Clarke, NF, Cuisset, JM, Roper, H, De Meirleir, L, D’Amico, A, Ben Yaou, R, Nascimento, A, Barois, A, Demay, L, Bertini, E, Ferreiro, A, Sewry, CA, Romero, NB, Ryan, M, Muntoni, F, Guicheney, P, Richard, P, Bonne, G, Estournet, B. De novo LMNA mutations cause a new form of congenital muscular dystrophy. Ann Neurol. 2008;64(2):177–86.Google Scholar